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In this paper we demonstrate that phage display technology is a suitable system for studying the interaction between the high-affinity receptor for 
IgE (FcsRI) and IgE. The a subunit extracellular domains of the human receptor were expressed on the surface of filamentous phage Ml3 fused 
to the carboxyl-terminal part of the gene III protein @III). Two constructs were made, the first with both the Ig-like domains of the receptor a 
chain and the second with only the C-terminal domain. The fusion genes were cloned in a phagemid vector to display monovalently the receptor 
on the phage surface. Our results indicate that the a receptor expressed on the phage is able to interact with IgE as demonstrated by an ELISA 
assay. In addition, by using the same system, we show that a single domain of the a receptor is sufficient for the interaction with IgE although 
with a binding afIinity lower than that of the two-domain receptor. 
Fc.sRI; Phage display; Receptor-immunoglobulin teraction 
1. INTRODUCTION 
The high-affinity receptor (FcERI) for immunoglob- 
ulin E (IgE) present on mast cells and basophils plays 
a key role in the allergic reaction. Bridging of receptor 
bound IgE by a multivalent allergen triggers cellular 
degranulation and release of mediators that are respon- 
sible for the clinical symptoms of type I immediate hy- 
persensitivity [l]. 
Fc&RI has a tetrameric structure consisting of three 
different subunits: one 01, one p and two y chains [2]. 
The 01 subunit is a member of the immunoglobulin su- 
perfamily and contains two Ig-like domains (hereafter 
the N-terminal domain is called D&l and the C-terminal 
D&2). Recently it has been clearly demonstrated that the 
extracellular part of the a chain is sufficient to produce 
interaction with IgE [3], and that it is fully functional 
in binding IgE with high affinity even after deglycosyla- 
tion [4]. The analysis of functional domains by using 
monoclonal antibodies has suggested that the binding 
region is located within the second domain [5]. Further- 
more chimeric receptors, engineered by exchanging ho- 
mologous regions of human FcyRII and Fc&RI, 
showed that the D&2 provides the binding specificity for 
IgE but is not sufficient for high affinity binding [6]. 
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Displaying polypeptides on the Ml3 phage surface is 
an effective method for selecting and screening protein 
variants with the properties desired. Each phage particle 
carries the gene encoding the foreign protein, together 
with the polypeptide itself packaged on its surface 171. 
The display of antibodies on the phage surface allowed 
protein mutants with higher affinity for the antigen to 
be selected [8]. Similar results were also obtained by 
engineering, as phage gene III fusions, proteins other 
than antibodies, such as human growth hormone [9,10] 
and bovine pancreatic trypsin inhibitor [l 11. 
This paper describes the expression of a functional 
FcERI on the phage surface. Our data indicate that the 
phage display is a suitable system to study FcsRI-IgE 
interaction. The displayed single domain (D&2) is suffi- 
cient for the interaction with IgE but shows a lower 
affinity than the two-domain (Dcl+D~2) receptor. The 
system described here is amenable to the construction 
of millions of different receptor mutants that can be 
affinity-selected using the cognate IgE as a ligand for 
the identification of residues involved in the binding. 
2. MATERIALS AND METHODS 
2.1. Cloning of Fe&RI a chain in the phagemid vector and rescuing of 
recombinant phage 
First strand cDNA was produced from RNA [12] of the KU8-12 
cell line [13]. PCR was performed on first strand cDNA with the 
oligonucleotide primers FczRI-1 (S’CGTGCTGCAGGTCCCTCA- 
GAAACCTAAGGTCTCCT) and FcsRI-2 (S’GATCGCGGCCGC- 
TCTACTTTTATTACAGTAATGTTGAGGG) to obtain the two- 
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domain construct (aa l-172) . To clone the single domain, De2 (aa 
8&-1721, the primer Fe&RI-3 (5’GCAGCTGCAGGACTGGCTGC 
TCCTTCAGGCCTCTG) was used instead of FcReI-1. The primers 
introduced two restriction sites (PstIINotI) for directional cloning of 
the insert. After digestion with the restriction enzymes, the inserts were 
hgated with the phagemid vector pHENS, kindly supplied by G. Cili- 
berto. This vector has been derived from pHEN1 [14] by deleting the 
N-terminal part of phage gene III. The inserts are produced as fusions 
with only the C-terminal part of pII (from aa 249) as shown in Fig. 1. 
Plasmids were transfected into the E. coli TGl strain and selected 
on LB (Lu~a-crania agar plates containing 100 fig/ml of ~p~~~llin 
and 1% (w/v) glucose. A single t~nsfo~~t was grown in 2 x YT with 
1% glucose and 100 &ml ~p~illin~ Superinfection was performed 
when the culture reached OD,= 0.300 by adding 10’ pfn (plaque 
forming units) per ml of culture of Ml3K07 wild type phage. Bacteria 
were kept at 37°C without shaking for 45 mm, and then 1 h with 
shaking at 300 rpm. At this point the glucose was removed by spinning 
down the cells and aspirating the supematant. Bacteria were grown 
for 20 h at 37°C in 2 x YT with 100 &ml of ampicillin and 20 @ml 
of kanamycin. Recombinant phage were purified and concentrated by 
two PEG precipitations [12b]. 
2.2. ELZSA assay 
Binding analysis of receptor phage to IgE was performed by ELISA. 
The hapten NIP-G% (5-I~o-4-hydrox~-3-nitrophena~tyI, succin- 
imide ester) was coupled to ovalbumin following the man~a~turers 
instructions (Cambridge Research Blochemicals). Nunc 96well Maxi- 
Sorp plates were chosen and a vohtme of lO~~l~el1 was used for all 
the incubations. Coating was performed with IO&ml of NIP ovalbu- 
min in 0.1 M carbonate buffer pH 8.6 at 4%’ o.n. Btocking was done 
with 1% BSA (bovine serum albumin) in PBS 1 h at r.t. Culture 
supernatant of the cell line JW815113 [15], which express the chimeric 
monoclonal antibody of IgE class, with human Fee and mouse varia- 
ble regions specific for the hapten NIP, were used to capture receptor 
phage. The culture supernatant of the cell line THG3-B5-13 [15] 
expressing IgG3 specific for the same hapten were used as control. The 
concentration of IgE and KgG3 in the culture supernatants was deter- 
mined with the Bind~~e EIA Kits (The binding site); IgE and IgG3 
were added to the ELISA plate at a ~on~ntration of 40 r&ml and 
incubated on. at 4°C. Several concentrations of phage and di~erent 
times of incubation were tried to set the reaction on saturation condi- 
tions, finally 5 x 10LL phage particles were added to each well and 
incubated for two hours at Ct.. After washing with PBS, 0.05% Tween- 
20, bound phage were detected with rabbit pofyclonal antibody raised 
against M13, followed by alkaline phospha~se-conjugated anti rabbit 
antibody (Pierce). The reaction was developed with 4nitrophenyl- 
phosphate in diethanolatnine buffer and the OD as was measured. 
Competition of binding was performed. Receptor phage (10”) were 
pre-incubated for 1 h at r.t. with dilutions of affinity-purified IgE from 
human myeloma (Scripps) non-reactive against he NIP hapten. After 
preincubation, receptor phage were added to the wells of an ELISA 
plate coated with NIP and anti-NIP immunogl~bulins, as described 
in the ELISA assay. 
3. RESULTS AND ~I§CUSSI~N 
3.1. Production of the Fc~Rlftision phage 
Several strategies have been proposed for the identifi- 
cation of the binding site for IgE on the Fc&RI. Inhibi- 
tion of IgE interaction with FcsRI has been performed 
with monoclonal antibodies recognising different re- 
gions of the receptor molecule [5]. Chimeric IgGtIgE 
receptors have been produced in COS cells to character- 
ise the minimum binding region [S]. The 01 chain of the 
receptor, a heavily gIy~osyla~~d protein, is responsible 
for the interaction with IgE and both its immunoglob- 
ulin-like domains are needed for a high-affinity binding 
[6]. Sugar residues are not crucial for binding [16,17] 
and it has recently been demonstrated that soluble re- 
combinant human a receptor can bind IgE with high 
affinity even after deglycosylation [4]. This observation 
opens up possibilities of producing a functional receptor 
in E. coli. 
On the basis of these considerations we have cloned 
regions of the u chain of the high-amity receptor for 
IgE as fusions with the phage gene III protein in the 
phagemid vector pHENS fFig.1). The expression unit 
of pHEN4 is under the control of an inducible promoter 
(PIacZ) and the signal sequence pelB [14] drives the 
secretion of the recombinant protein into the periplas- 
mic space. The vector contains a B lactamase gene, the 
ColE 1 replication origin and the phage M 13 intergenic 
region. It can be propagated as a common plasmid but, 
upon infection with helper phage, it is packaged into 
virion like particles. The phagemid system should allow 
the production of phage particles carrying on average 
one copy of r~omb~ant pIII protein per phage virion 
[7f. This system was chosen since “monovalent’ phage 
display appears to enhance the discrimination between 
phage with different affinities f7,9]. The N-terminal part 
of pII present in the original pHEN1 vector was de- 
leted assuming that in a shorter fusion product the tar- 
get protein would be more accessible for binding as 
described for the human growth hormone [7,8]. Moreo- 
ver, we introduced an amber codon between the inserts 
and the pII1 sequence to express the recombinant pro- 
teins in soluble form by using an E. coli non-suppressor 
strain. 
A - PeIB-leader 
B - PeIB-leader 
Fig. 1. Schematic repres~tat~on of the fusion products: (A) two-domain receptor and (B) sin~~d~main receptor. Numbers refer to the position 
of amino acids. 
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Fig. 2. Saturation curve of the binding to IgE of phage FCERI 
D.sl+D.s2 (-o-) and FcsRI D&2 (-A-). 
The extracellular part of the a chain of the IgE recep- 
tor, composed of two Ig-like domains, and a deletion 
mutant containing only the second domain (D&2) were 
cloned in this system (Fig. 1). We obtained routinely 
10” fusion phages per ml of superinfected cells, titrated 
as ampicillin-transducing units. 
3.2. Binding of phage Fe&RI to IgE 
In order to analyse the Fc&RI-IgE interaction we 
have set up an ELISA assay. IgE reactive against a 
hapten, NIP, were captured on the ELISA plate coated 
with this hapten so that the immunoglobulins were ori- 
ented in such a way that the Fc would be free to interact 
with its receptor present on the phage surface. This 
experiment shows that both the two-domain receptor 
(D&l+D&2) and the single-domain (D&2) bind IgE, but 
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Fig. 3. Binding to IgE and to IgG3 of phage FczRI Del+De2 (A) and 
Fc.sRI De2 (B) measured by ELISA. Symbols: IgE (a), and IgG3 (0) 
The values of background reaction of the wild type phage have been 
subtracted from the O.D.,, values obtained with the recombinant 
phage. 
there is a difference for the maximum binding achieved 
under saturation conditions (Fig. 2). The OD do5 values 
are, in fact, lower for the D&2 receptor. Preliminary 
experiments (data not shown) suggest hat this differ- 
ence in maximum binding obtained for the two recep- 
tors is a consequence of the partial loss of D&2 bound 
phage during the two hours incubation with the reveal- 
ing antibodies before the development of the binding 
reaction occurs. The specificity of the IgE-FcsRI reac- 
tion was controlled using immunoglobulins of a differ- 
ent isotype, IgG3, but reactive against the same hapten 
(Fig. 3). The specificity of the binding was further inves- 
tigated with competition experiments using an excess of 
IgE non-reactive to the hapten NIP. The percentage of 
inhibition of the ELISA reaction was measured and the 
curve of inhibition for both receptor phages is shown in 
Fig. 4. The comparison of the two curves clearly indi- 
cate that the D&2 receptor binds IgE with lower affinity. 
The production of soluble receptors is in progress for 
an accurate measurement of the dissociation constants. 
Our data offer the first indication that a functional 
receptor can be produced on the phage surface. The 
receptor phage system is a feasible approach and could 
be very helpful in characterising the binding region 
within the receptor. A previous report has demon- 
strated, by using chimeric human FcyRIIIFcsRI, that 
a single domain (D&2) of the FcsRI is sufficient for IgE 
binding. Here we show that the D&2 provides binding 
specificity for IgE working also in a structural context 
different from that of immunoglobulin receptors. 
Functional proteins other than receptors, such as an- 
tibodies and hormones have been displayed as gene III 
fusions [8,10], showing that the phage display is a pow- 
erful system to select higher affinity binding mutants. 
The construction of a receptor mutant library could 
allow the identification, using a selection system similar 
to the one described here, of an improved form of the 
high-affinity receptor for IgE. Recently, several reports 
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Fig. 4. Competiton of phage FcERI D&l+D&2 (a-) and FcsRI D&2 
(-A-) binding obtained by preincubation with several dilutions of com- 
petitor. 
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describe the ‘in viva’ use of soluble recombinant recep- 
tors as antagonist of the corresponding cytokines (i.e. 
IFN-y receptor, [18,19]; IL4 receptor, [20]; IL1 recep- 
tor, [21]; TNF receptor, [22]) supporting the hypothesis 
that a soluble improved Fc&RI, capable of efficiently 
competing the natural one, could be of great therapeutic 
interest. 
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